# 📜 Publication 2 Strategy: Comparative AI-CADD Profiling
**Title:** "Comparative Phytochemical-Pharmacological Profiling Through AI-Integrated CADD: Multi-Target Alzheimer's Lead Discovery of Various Medicinal Plants Extracts and its Isolated Compounds"
**Target Journal:** *Journal of Cheminformatics* / *Phytomedicine* / *Journal of Ethnopharmacology*

---

## 🎯 Core Research Scope
This paper is a **Comparative Study**. It benchmarks "Plant A" vs "Plant B" (and potentially "Plant C" or Reference Standard) to see which has the best multi-target profile for Alzheimer's.

**The "various medicinal plants":**
1.  *Evolvulus alsinoides*
2.  *Cordia dichotoma*
3.  *(Optional Reference)*: *Ginkgo biloba* or *Bacopa monnieri* (Virtual Reference)

**The "Isolated Compounds":**
*   Specific focus on key isolates (e.g., Quercetin, Rutin, Kaempferol, Caffeic Acid) found within these extracts.

---

## 🏗️ 7-Phase Workflow (Aligned to Title)

### Phase 1: Comparative Phytochemical Profiling (In Silico)
*   **Input:** LC-MS/GC-MS lists for Plant A and Plant B.
*   **Action:** Create "Virtual Libraries" for each plant extract.
*   **AI Task:** Use the Tier 2 Ensemble Model to screen *all* constituents.
*   **Output:** A "Bio-Activity Heatmap" comparing the phytochemical diversity and AD-potential of Plant A vs Plant B.

### Phase 2: AI-Integrated Lead Identification
*   **Innovation:** "Phytochemical Domain Adaptation" (Fine-tuned ChemBERTa).
*   **Analysis:**
    *   **Extract Level:** Which plant has a higher *Hit Rate*?
    *   **Compound Level:** Which specific Isolates drive the activity?
*   **Deliverable:** A ranked list of "Multi-Target Leads" (MTDLs) that hit AChE + BACE1 + GSK3β simultaneously.

### Phase 3: Pharmacological Profiling (ADMET)
*   **Focus:** BBB Permeability & Neurotoxicity.
*   **Comparison:** Compare the *Safety Profiles* of the two extracts based on their constituent makeup.

### Phase 4: Molecular Docking (Mechanism of Action)
*   **Action:** Consensus Docking (AutoDock Vina) of the Top 3 Isolates from each plant.
*   **Target:** Binding interactions at the *Catalytic Triad* (AChE) and *Allosteric Sites*.

### Phase 5: Molecular Dynamics (Stability)
*   **Action:** 10ns MD Simulation for the best compound from *each* plant.
*   **Comparison:** Comparative stability analysis (RMSD/RMSF) – "Is the *Evolvulus* compound more stable than the *Cordia* compound?"

### Phase 6: Network Pharmacology (Systems View)
*   **Add-on:** Construct a Compound-Target-Pathway network.
*   **Visual:** Show how multiple compounds in the extract work synergistically (if applicable).

### Phase 7: Conclusion & Standardization
*   **Verdict:** "Based on AI-CADD profiling, *[Plant Name]* shows superior multi-target potential..."
*   **Lead Proposal:** The specific isolated compound recommended for in vivo testing.

---

## 📅 Execution Roadmap (Dec 14 - Jan 10)

| Week | Activity | Goal |
| :--- | :--- | :--- |
| **Week 1** | **Data & Training** | Fine-tune Tier 2 Model. Ingest LC-MS data for all plants. |
| **Week 2** | **AI Profiling** | Run the "Comparative Screen". Generate Heatmaps (Plant A vs Plant B). |
| **Week 3** | **Structural Validation** | Docking & MD for Top Isolates. |
| **Week 4** | **Writing** | Draft the paper with the specific title structure. |

---

## 🧪 Colab Script Adjustment
To support "Comparative Profiling", the script needs to:
1.  Accept **Multiple Lists** of SMILES (one for each plant).
2.  Output **Distribution Plots** (Box plots of predicted pIC50 for Plant A vs Plant B).
3.  Highlight **Isolates** explicitly in the results.

